Shennon Biotechnologies
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
$12MFunding
ParticipantActivity from announced rounds
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
Develops synthetic audience models to simulate real-world human thinking and behaviour